Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus ErythematosusSkin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosusEnrolling by invitationPhase 32026-10-02NCT04976322

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
UCB Biopharma SRL30

123 results · Page 1 of 5

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Sl0046 20019GuangzhouChina1
Sl0046 20020ShanghaiChina1
Sl0046 20025WenzhouChina1
Sl0046 20082TaiyuanTaiwan1
Sl0046 20095TaipeiTaiwan1
Sl0046 20104SeoulSouth Korea1
Sl0046 20108IncheonSouth Korea1
Sl0046 20113TaichungTaiwan1
Sl0046 20128BeijingChina1
Sl0046 20132ZhengzhouChina1
Sl0046 20136TianjinChina1
Sl0046 20142TaichungTaiwan1
Sl0046 20171SendaiJapan1
Sl0046 20180WuhanChina1
Sl0046 20181MakatiPhilippines1
Sl0046 20182Davao CityPhilippines1
Sl0046 20204SuzhouChina1
Sl0046 20273YangzhouChina1
Sl0046 20287NagoyaJapan1
Sl0046 20290GuilinChina1
Sl0046 20291ChangchunChina1
Sl0046 20346ShantouChina1
Sl0046 40027HerneGermany1
Sl0046 40031SzegedHungary1
Sl0046 40044PoznanPoland1